HYBRIDOMICS

Welcome to the Brand page for “HYBRIDOMICS”, which is offered here for Biopharmaceutical preparations for use in the treatment of cancer, infectious disease and autoimmune disease, including hybridoma-generated antibodies and mammalian antibodies including human antibodies; biopharmaceutical and biotechnology reagents for medical diagnostic use;chemical products for use in manufacturing in the biopharmaceutical industry and biotechnology industry; biopharmaceutical and biotechnological reagents for scientific and medical research use;medical and scientific research services including preparation and development of hybridoma-derived antibodies and product development services for others;.

Its status is currently believed to be active. Its class is unavailable. “HYBRIDOMICS” is believed to be currently owned by “Viventia Biotech Inc.”